[{"address1": "18000 Studebaker Road", "address2": "Suite 800", "city": "Cerritos", "state": "CA", "zip": "90703", "country": "United States", "phone": "562 735 3226", "website": "https://theoncologyinstitute.com", "industry": "Medical Care Facilities", "industryKey": "medical-care-facilities", "industryDisp": "Medical Care Facilities", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.", "fullTimeEmployees": 825, "companyOfficers": [{"maxAge": 1, "name": "Dr. Daniel  Virnich FACHE, M.B.A., M.D.", "age": 45, "title": "CEO & Executive Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 704251, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 573764, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Carter", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Austin  Lee", "title": "VP of Accounting & Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristin  England", "title": "Chief Administrative Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Hueppelsheuser Esq.", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jordan  McInerney", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Cella", "title": "Senior Vice President of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey  Langsam M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.49, "open": 3.49, "dayLow": 3.465, "dayHigh": 3.59, "regularMarketPreviousClose": 3.49, "regularMarketOpen": 3.49, "regularMarketDayLow": 3.465, "regularMarketDayHigh": 3.59, "payoutRatio": 0.0, "beta": 0.192, "forwardPE": -21.875, "volume": 2026203, "regularMarketVolume": 2026203, "averageVolume": 2308607, "averageVolume10days": 1739710, "averageDailyVolume10Day": 1739710, "bid": 2.78, "ask": 4.49, "bidSize": 2, "askSize": 2, "marketCap": 344334720, "fiftyTwoWeekLow": 0.195, "fiftyTwoWeekHigh": 4.88, "allTimeHigh": 12.66, "allTimeLow": 0.125, "priceToSalesTrailing12Months": 0.74686676, "fiftyDayAverage": 3.7299, "twoHundredDayAverage": 3.011315, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 420300704, "profitMargins": -0.14376001, "floatShares": 84878501, "sharesOutstanding": 98381340, "sharesShort": 6567704, "sharesShortPriorMonth": 4788151, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0668, "heldPercentInsiders": 0.08636, "heldPercentInstitutions": 0.40273997, "shortRatio": 2.23, "shortPercentOfFloat": 0.0806, "impliedSharesOutstanding": 98381340, "bookValue": -0.126, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -54704000, "trailingEps": -0.64, "forwardEps": -0.16, "enterpriseToRevenue": 0.912, "enterpriseToEbitda": -12.331, "52WeekChange": 16.156862, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 3.5, "targetHighPrice": 8.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 27658000, "totalCashPerShare": 0.281, "ebitda": -34086000, "totalDebt": 103624000, "quickRatio": 1.336, "currentRatio": 1.679, "totalRevenue": 461039008, "revenuePerShare": 5.366, "returnOnAssets": -0.14989, "returnOnEquity": -41.3217, "grossProfits": 68306000, "freeCashflow": -10884625, "operatingCashflow": -23634000, "revenueGrowth": 0.367, "grossMargins": 0.14816, "ebitdaMargins": -0.07393, "operatingMargins": -0.05898, "financialCurrency": "USD", "symbol": "TOI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1766192369, "regularMarketTime": 1766178001, "exchange": "NCM", "messageBoardId": "finmb_661363343", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "The Oncology Institute, Inc.", "fiftyTwoWeekChangePercent": 1615.6863, "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1763071200, "earningsCallTimestampEnd": 1763071200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.64, "epsForward": -0.16, "shortName": "The Oncology Institute, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591277400000, "postMarketChangePercent": -4.5714307, "postMarketPrice": 3.34, "postMarketChange": -0.16000009, "regularMarketChange": 0.00999999, "regularMarketDayRange": "3.465 - 3.59", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2308607, "fiftyTwoWeekLowChange": 3.305, "fiftyTwoWeekLowChangePercent": 16.948719, "fiftyTwoWeekRange": "0.195 - 4.88", "fiftyTwoWeekHighChange": -1.3800001, "fiftyTwoWeekHighChangePercent": -0.2827869, "regularMarketChangePercent": 0.286533, "regularMarketPrice": 3.5, "fiftyDayAverageChange": -0.22989988, "fiftyDayAverageChangePercent": -0.06163701, "twoHundredDayAverageChange": 0.4886849, "twoHundredDayAverageChangePercent": 0.16228288, "priceToBook": -27.777777, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "The Oncology Institute", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]